Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05643365

Factors Affecting Timing of Hypothyroidism Following Radioactive Iodine Therapy Patients With Graves Disease

Conditions: Radioactive Iodine-Induced Hypothyroidism in Graves Disease Patients

Sex: All

Ages: 13 Years – 70 Years

Enrollment: 100

Sponsor: Assiut University

Location: Egypt

Summary

The purpose of this retrospective study was to clarify the possible risk factors of early hypothyroidism after RAI therapy in Graves' disease.

Eligibility Criteria

Inclusion Criteria:Graves' disease patients after one year of RAI therapy .Suppressed serum thyrotropin (TSH) <0.55 µU/ml , elevated serum free triiodothyronine (FT3) > 6.5 pmol/L , free thyroxin FT4 >22.7 pmol/L .Exclusion Criteria:Patients with other causes of hyperthyroidism , such as toxic multinodular goiter and single toxic adenomaThyroid cancerRecurrent GDPrevious Thyroid surgeryPatients can't complete the follow -up within 6 months.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05643365). StuddyBuddy aggregates publicly available trial information.